Publications

Publications

 

  • Hooks, J.C.; Matharage, J.P.; Udugamasooriya, D.G.; Development of Homomultimers and Heteromultimers of Lung Cancer Specific Peptoids; Biopolymers-Peptide Science, 2011, 96(5), 567-577.
  • Napolitano, R.; Soesbe, T.C.; De León‐Rodríguez, L.M.; Sherry, A.D.; Udugamasooriya, D. G.; Onbead combinatorial synthesis and imaging of CEST‐MRI agents to identify factors that influence water exchange, J. Amer. Chem. Soc., 2011, 133, 13023-30.
  • De León‐Rodríguez, L. M.; Lubag, A.; Udugamasooriya, D.G.; Sun, X.; Kodadek,T.; Sherry, A.D.; MRI detection of VEGFR2 in vivo using a low molecular weight peptoid-(Gd)8-dendron for targeting; J. Amer. Chem. Soc., 2010, 132(37), 12829-31.
  • Lynn, K.D.; Udugamasooriya, D.G.; Roland, C.L.; Castrillon, D.H.; Kodadek, T.J.; Brekken, R.A.; GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer, BMC Cancer, 2010, 10(1), 397.
  • Lee, J.; Udugamasooriya, D.G.; Lim, H.S.; Kodadek, T.; Potent and Selective Photo-inactivation of Proteins with Peptoid-Ruthenium Conjugates; Nature Chemical Biology, 2010, 6, 258-260.
  • Rubini C.; Ruzza P.; Spaller M.R.; Siligardi G.; Hussain R.; Udugamasooriya D.G.; Bellanda M.; Mammi S.; Borgogno A.; Calderan A.; Cesaro L.; Brunati A.M.; Donella-Deana A.; Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC and NMR studies; Biopolymers, 2010, 94(3), 298-306.
  • Gocke, A.; Udugamasooriya, D.G.; Archer, C; Lee, J.; Kodadek, T.; Isolation of Antagonists of Antigen-Specific Autoimmune T Cell Proliferation; Chemistry and Biology, 2009, 16(11):1133-9.
  • Roland C.L.; Lynn K.D.; Toombs J.E.; Dineen S.P.; Udugamasooriya D.G.; Brekken R.A.; Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer; PLoS One, 2009, 4(11), e7669.
  • Muders, M.H.; Wang, L., Dutta; S.K., Wang, E.; Ikeda, Y.; Udugamasooriya; D.G.; Memic, A.; Rupasinghe, C.; Baretton, G.; Datta, D.; Simons, M.; Spaller, M.R.; Mukhopadhyay, D.; GIPC/Synectin as  a New Target in Pancreatic Cancer Treatment; Clinical Cancer Research, 2009, 15(12), 4095-103.
  • Udugamasooriya, D.G.; Ritchie, C.; Brekken, R.A.; Kodadek, T.; A Peptoid Antagonist of  VEGF Receptor 2 Recognizes A “Hotspot” In the Extracellular Domain Distinct From The Hormone-Binding Site; Bioorganic & Medicinal Chemistry, 2008, 16(12), 6338-6343.
  • Udugamasooriya, D.G.; Dunham, G.; Ritchie, C.; Brekken, R.A.; Kodadek, T.; The Pharmacophore of a Peptoid VEGF Receptor 2 Antagonist Includes Both Side Chain and Main Chain Residues; Bioorganic & Medicinal Chemistry Lett.,  2008, 18(22), 5892-5894.
  • Astle, J.M.; Udugamasooriya, D.G.; Smallshaw, J.E.; Kodadek, T.; A VEGFR2 antagonist and other peptoids evade immune recognition; Int J Pept Res Ther., 2008, 14, 223-227.
  • Udugamasooriya, D.G.; Dineen, S.P.; Brekken, R.A.; Kodadek T.; A Peptoid “Antibody Surrogate” That Antagonizes VEGF-VEGF Receptor 2 Interaction, J. Amer. Chem. Soc., 2008, 130, 5744-5752.
  • Shores, K.; Udugamasooriya; D.G.; Kodadek, T.; Knapp, D.R.; Use of peptoid libraries for low abundance protein enrichment in proteomic analysis, The journal of Proteomic Research, 2008, 7(5), 1922–1931.
  • Udugamasooriya, D.G.; Spaller, M.R.; Conformational Constraint in Protein Ligand Design and the Inconsistency of Binding Entropy; Biopolymers, 2008, 89(8), 653-667.
  • Udugamasooriya, D.G.; Sharma, S.C.; Spaller, M.R.; A Parallel Chemistry Approach to Organic-Modified Peptide Ligands for PDZ Domain Proteins: A Synthetic, Thermodynamic and Structural Investigation; ChemBiochem, 2008, 9(10), 1587-1589.
  • Udugamasooriya, G.; Saro, D.; Spaller, M.R.; Bridged Peptide Macrocycles as Ligands for PDZ Domain Proteins; Org. Lett. 2005, 7, 1203 -1206.
  • Deraniyagala, S.A.; Udugamasooriya, D.G.; De Silva, E.D.; Williams, D.E.; Anderson, R.J.; Rosmarinic Acid and Methyl Rosmarinate from Heliotropium indicum; J. Trop. Med. Plants, 2002, 3, 25-28.